Benzinga | Nov 12, 2020 04:11PM EST

Biolase Q3 EPS $(0.21) Misses $(0.05) Estimate, Sales $6.50M Inline

Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.05) by 320 percent. This is a 16 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $6.50 million which met the analyst consensus estimate. This is a 24.82 percent decrease over sales of $8.65 million the same period last year.